Company / Free Cash Flow
KESTRA MEDICAL TECHNOLOGIES, LTD. Free Cash Flow History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$100.5M
FY2024
5-year range
-$100.5M / -$84.5M
FY2023-FY2024
Trend
-19.0%
vs FY2023
Sector context
#143 of 151
Health Care
What the data says
Among 151 Health Care companies, KESTRA MEDICAL TECHNOLOGIES, LTD. is in the bottom 5% for free cash flow.
Based on SEC 10-K filings.
-$101M in FY2024.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 151This company -$100.5M Sector average $779.8M
▼
-112.9% below sector average
Key checks
Key Insights
- In FY2024, free cash flow decreased 19.0% year-over-year.
- Ranks #143 out of 151 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.01 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | -$100.5M | -19.0% |
| FY2023 | -$84.5M | - |
As of FY2024 · SEC 10-K · Updated Mar 29, 2026